Lupin Wins FDA Approval for UCD Oral Liquid Drug
MUMBAI, India & NAPLES, Fla., May 5, 2026 Lupin Limited, a global pharmaceutical leader, has announced that it has...
Lupin
Advertisement
Lupin Launches Dapagliflozin Tablets in U.S. Market
Mumbai, India & Naples, Florida | April 10, 2026 Lupin Limited has announced the U.S. launch of Dapagliflozin Tablets...
Lupin Gains US FDA Nod for Dapagliflozin Tablets
MUMBAI, India and NAPLES, Fla., April 7, 2026 Lupin Limited has received approval from the U.S. Food and Drug...
Lupin Gains FDA Nod for Sugammadex Injection in US
MUMBAI, India & NAPLES, Fla., USA, March 31, 2026 Lupin Limited has received tentative approval from the U.S. Food...
Lupin Gets FDA Nod for Pitolisant Tablets
MUMBAI, INDIA & NAPLES, USA | March 25, 2026 Lupin Limited, a global pharmaceutical leader, has received tentative approval...
Advertisements
FDA Supports Consegna CP217 for Opioid Overdose Care
February 24, 2026 – Pittsburgh, Pennsylvania, USA Consegna Pharma, Inc. has announced that the U.S. Food and Drug Administration...
Lupin Launches Brivaracetam Oral Solution in US
February 24, 2026 – Mumbai, India & Naples, Florida, USA Global pharmaceutical leader Lupin Limited has announced that it...
Lupin Launches Topiramate ER Capsules in United States
MUMBAI, India & NAPLES, Fla., Feb. 4, 2026 — Global pharmaceutical company Lupin Limited announced the U.S. launch of...
Lupin Debuts CGT-Exclusive Risperidone LAI in U.S. Market
Dateline: November 14, 2025 — Mumbai, India / Baltimore, MarylandLupin has launched its Risperidone Long-Acting Injectable (LAI) in the...
Advertisement
